What IDEAYA Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 2 | 3 |
| Total trades | 3 | 8 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 26,338 | 88,182 |
| Disposed | 26,338 | 35,888 |
| Net activity | +0 | +52,294 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hata Yujiro S | President and CEO | Oct 06 | Disclosed 10b5-1 sale · S | −800 | $38.26 | −$30.6K | 690,695 |
| Hata Yujiro S | President and CEO | Oct 06 | Disclosed 10b5-1 sale · S | −25,538 | $37.39 | −$955K | 691,495 |
| Hata Yujiro S | President and CEO | Oct 06 | Exercise / conversion · M | +26,338 | $4.31 | +$114K | 717,033 |
| Ruiz Briseno Andres | Chief Accounting Officer | Jul 07 | Open-market sale · S | −9,550 | $40.01 | −$382K | 26,466 |
| Ruiz Briseno Andres | Chief Accounting Officer | Jul 07 | Exercise / conversion · M | +9,550 | $12.86 | +$123K | 36,016 |
| Stein Jeffrey | Director | Mar 02 | Open-market buy · P | +50,000 | $32.96 | +$1.65M | 54,281 |
| Ruiz Briseno Andres | See Remarks | Nov 28 | Grant / award · A | +1,253 | $16.91 | +$21.2K | 26,466 |
| Snyder Douglas B. | SVP, General Counsel | Nov 28 | Grant / award · A | +1,041 | $16.91 | +$17.6K | 2,080 |
| Snyder Douglas B. | SVP, General Counsel | May 30 | Grant / award · A | +1,039 | $16.91 | +$17.6K | 1,039 |
| Hata Yujiro S | President and CEO | Feb 18 | Exercise / conversion · M | +12,808 | $19.52 | +$250K | 690,695 |
| Ruiz Briseno Andres | See Remarks | Nov 29 | Grant / award · A | +682 | $23.26 | +$15.9K | 25,213 |
| Throne Jason | Chief Legal Officer | Jun 27 | Exercise / conversion · M | +47,060 | $7.01 | +$330K | 63,484 |
| Throne Jason | Chief Legal Officer | Jun 27 | Exercise / conversion · M | +6,424 | $13.34 | +$85.7K | 16,424 |
| White Michael Anthony | Chief Scientific Officer | May 29 | Disclosed 10b5-1 sale · S | −851 | $36.78 | −$31.3K | 0 |
| White Michael Anthony | Chief Scientific Officer | May 29 | Disclosed 10b5-1 sale · S | −27,649 | $36.23 | −$1M | 851 |
| White Michael Anthony | Chief Scientific Officer | May 29 | Exercise / conversion · M | +28,500 | $12.86 | +$367K | 28,500 |
| Hata Yujiro S | President and CEO | May 16 | Disclosed 10b5-1 sale · S | −4,349 | $42.37 | −$184K | 677,887 |
| Hata Yujiro S | President and CEO | May 16 | Disclosed 10b5-1 sale · S | −30,084 | $41.73 | −$1.26M | 682,236 |
| Hata Yujiro S | President and CEO | May 16 | Exercise / conversion · M | +34,433 | $4.31 | +$148K | 712,320 |
| Hata Yujiro S | President and CEO | May 15 | Disclosed 10b5-1 sale · S | −503 | $44.12 | −$22.2K | 677,887 |
Loading...
